SCHEMBL8073258

SCHEMBL8073258

Bc1ncc(C(=O)O)n1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HCAR2 Q8TDS4 2/20 0.35
KDM4E B2RXH2 5/20 0.35
MCL1 Q07820 2/20 0.35
GPR35 Q9HC97 1/20 0.35
GRN P28799 1/20 0.35
SORT1 Q99523 1/20 0.35
HSD17B10 Q99714 5/20 0.33
GFER P55789 1/20 0.33
GLA P06280 1/20 0.33
ATM Q13315 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
ALDH1A1 P00352 5/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 2/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8081105 0.79 SMN1; SMN2 (0.48) L3MBTL1MEN1KMT2AKDM4EHSD17B10
SCHEMBL17450551 0.78 KDM4E (0.41) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL7996974 0.77 KMT2A (0.38) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL17450552 0.77 GPR35 (0.40) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL19175805 0.75 CYP1A2 (0.44) L3MBTL1MEN1KMT2AKDM4EMCL1
SCHEMBL13982981 0.75 L3MBTL1 (0.38) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL3496090 0.75 MCL1 (0.40) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL3400738 0.75 MEN1 (0.43) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL23235966 0.72 MEN1 (0.36) L3MBTL1MEN1KMT2AHCAR2KDM4E
SCHEMBL12740595 0.72 HTT (0.55) L3MBTL1MEN1KMT2AKDM4EMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009012252-A1 AMINOALKYLAZOLE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS WYETH (US) 2009-01-22 WO disclosed